IP Offerings Logo

Patent MarketPlace: Medical Device Patents for Sale

Medication Dispenser (Mauk): U.S. Patent No. 7,584,849

As America ages, a larger and larger portion of the population needs to take one or more prescription drugs on a regular basis. In fact, 85% of Americans over 60 take at least one prescription drug once a day. In addition to this, many younger, healthier Americans take vitamins and supplements on a regular basis. The challenge for both groups is keeping track of what drug or vitamin or supplement has and has not been taken each day.

This patent creates a tool for those who take drugs, vitamins, and/or supplements to make sure that no dosage is missed and the user does not double-dose. The device has adjustable slots that hold the bottles of medications, vitamins, or supplements, and a grid of pill dispensers, four (Morning, Noon, Evening, and Bedtime) for each day of the week for a total of 28. The user or caregiver fills each dispenser slot once a week with the pills or capsules to be taken at each time of the day. The unit includes an electronic display that shows what time of day it is. If a dispenser slot is empty, that means the user took those pills. If there are still pills in the slot, he or she forgot, and needs to take them. It also includes a slide-out drawer that holds a record of the patient’s prescriptions and dosages.

This invention insures that the user takes the medicines prescribed for him or her, along with the vitamins and supplements the user is taking, as prescribed. It eliminates the user – often an older person with diminished mental acuity – from both forgetting to take his or her medicine and accidentally double-dosing. U.S. Patent No. 7,584,849 for a “Home medication station” would enable a supplier of healthcare products to offer a highly useful product that purchasers will use and appreciate.

Specialized Skin Exfoliation (Perez): U.S. Patent No. 8,585,621

The skin is the largest organ in the human body. The outer layer of skin is continually dying and being replaced by new skin that replaces it. When a person gets a tan, that tan is a layer of darker, dead skin. Elbows, however, create a special problem. Dead skin builds up on the elbows, causing them to get darker and darker, creating a condition known as “Dark Elbows.” While Dark Elbows are not a health hazard, they can be very unattractive. This patent creates a device that specifically addresses Dark Elbows and other specialized skin exfoliation needs.

This patent creates a tabletop or floor-based skin exfoliation device that is enclosed in a housing. The user turns it on and places his or her elbows on the top surface of the device. The vibrating abrasive surface gently cleans away the dead skin from the elbows, eliminating Dark Elbows, and leaving a consistent skin tone on the user’s arms. The unit can also be placed on the floor, and the user can place his or her feet on the device to remove dead skin from the heels and soles of the feet. For the treatment of Dark Elbows, and for exfoliating feet, this device is clearly superior to the current generation of handheld exfoliation devices that are on the market.

U.S. Patent No. 8,585,621 for a “Skin exfoliation apparatus” would be a strategic acquisition for any manufacturer of exfoliation products looking to expand its product offerings, or for any medical device manufacturer seeking to expand into the huge exfoliation market with a unique, patent-protected product.

Laminitis Treatment for Horses (Medergo): U.S. Patent No. 8,465,444 and European Patent Application

Horses are smart, affectionate, and incredibly loyal. It is a shame that hundreds of horses a year have to be euthanized because they suffer from laminitis - an inflammation of the soft tissue structures that attach the coffin or pedal bone of the foot to the hoof wall known as “laminae” – and they cannot be effectively treated. As laminitis (also known as “founder”) progresses, a horse can eventually not stand or walk, and the horse must be put down. Such a tragedy for such wonderful animals that have been bred and raised and cared for by humankind for centuries.

This portfolio creates an effective and affordable treatment for laminitis. The invention is a garment wrap that is secured to the animal's leg and includes inflatable chambers that engage critical points on the horse’s leg and hoof. The inflatable chambers are pressurized in a sequence that prevents backflow from a more proximal point on the animal's leg to a more distal point on the leg. A boot with an inner sole pad is also used during the therapy procedure and afterwards, and the inner sole pad can be used to administer medications as well as for an iontophoresis procedure. The boot assists with other treatments to increase circulation to aid healing in the hoof by increasing blood flow.

Wounds and problems of the legs of horses are the result of poor circulation along with lymphedema, venous stasis, trauma, cellulitis, and postsurgical swelling. In addition to treatment of laminitis, this invention can be used as a rehabilitative device as well as a conditioning tool for animals that are recuperating from other conditions. This treatment for horses was developed from a similar method used with great success on thousands of human patients with circulatory issues.

This portfolio includes U.S. Patent No. 8,465,444 and European Patent Application 2983634 for “Laminitis treatment system and method.” The acquirer of this portfolio can create the first effective and affordable – as well as life-saving – treatment for laminitis in hoofed animals with patent protection on two continents.

Next-Generation Electrotherapy (Li): U.S. Patent No. 10,471,253

The earth is a huge magnet with a positive and negative pole. All animals on the earth carry that same positive and negative magnetic charge, including all humans. Electrotherapy – the application of low-voltage electric current through the human body – has been proven to treat many conditions, from relieving pain to healing wounds, by improving the electromagnetic balance in the body. Also known as electromagnetic therapy, the treatment of diseases and afflictions via electrotherapy goes back over 200 years. The first recorded use of electrotherapy was by Johann Gottlob Krüger in 1743. John Wesley, an Anglican clergyman and the founder of the Methodist Church, was a proponent of electrotherapy.

This patent takes electrotherapy to the next level by creating a device for applying a carefully controlled and regulated flow of electrons to the human body in a field between positive and negative electrodes. It includes an electric field detector that measures and transmits data about the strength of the actual electric field back to the operator. A microprocessor receives this data and compares it against the parameters of a wellness-promoting electric field so the pulse-width modulator is operating at optimal performance. The wellness of a patient is enhanced by ensuring that the positive electrode is in correct approximation to a positive location on the patient and the negative electrode is in correct approximation to a negative location on the patient. A flow of electrons at the right strength has been documented to treat such maladies as depression, muscle pain, constipation, sinus infection, low blood pressure, nausea and vomiting, insomnia, infertility, asthma and tinnitus, to name just a few.

U.S. Patent No. 10,471,253 for a “System and method to modulate an electric field in an environment” would enable a medical device manufacturer to introduce a product for those seeking treatment of their disease or condition via a controlled electrical field.

Capsule that Diagnoses and Treats Intestinal Tract (Entrack): International Patent Portfolio

In Isaac Asimov’s “Fantastic Voyage,” a ship and a medical crew were shrunk to microscopic size to perform diagnosis and surgery from within the body. Asimov’s visions are realized in part in this portfolio. It provides broad coverage of an autonomous swallowable capsule that can pass through the gastrointestinal (GI) tract of a body to diagnosis and/or treat conditions in the GI tract. As it passes through the intestinal tract, the capsule can perform one or more diagnostic functions – detect the presence of blood or other abnormal tissue conditions, for example. It can also report its location and findings wirelessly. This allows for the development of a diagnostic map of the GI tract which can be used by a physician to pinpoint the location of an adverse condition such as a polyp in the colon. Additionally, the capsule can be programmed to deliver medication or other treatments to a selected tissue site or to mark the tissue site for later treatment. The capsule covered by this portfolio can reduce or totally eliminate the need to perform more costly invasive procedures such as colonoscopies and GI surgeries.

Patent No.Title
US 7,160,258Capsule and method for treating or diagnosing the intestinal tract
US 7,824,347System for marking a location for treatment within the gastrointestinal tract
US 8,005,536Capsule and method for treating or diagnosing conditions or diseases of the intestinal tract
US 8,517,961System for marking a location for treatment within the gastrointestinal tract
US 8,617,070Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract
US 8,915,867System for marking a location for treatment within the gastrointestinal tract
US 9,167,990Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract
US 9,414,768Capsule and method for treating or diagnosing conditions or diseases of the intestinal tract
US 9,456,774System for marking a location for treatment within the gastrointestinal tract
US 10,226,608Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract

The portfolio also includes European Patent 1408820 for a “Capsule for treating or diagnosing the intestinal tract,” Australian Patent 2002315385 for a “Diagnostic capsule and method of use” and Canadian Patent 2451807 for a “Capsule and method for treating or diagnosing the intestinal tract” as well as U.S. Patent Applications 20170007154 and 16/254,783 for “Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract.”

This is both a robust and a foundational patent portfolio. The U.S. Patents in the portfolio share a 2001 Priority Date, and each U.S. Patent has at least 400 Forward Citations! This portfolio would be a strategic acquisition for any medical device manufacturer!

Bacteria Biosensor Detection System (Edmonson): Two U.S. Patents, Canadian Patent and Prototypes

When examining a patient, and a bacterial infection is suspected, it is important for the physician to know quickly if live bacteria are present. Farmers need to know if bacteria are present that can be a threat to their crops and feedstocks. Food processing plants need to be able to quickly detect if bacteria are present in food processing, handling and storage equipment and locations. The invention covered by this portfolio addresses exactly that need by creating a low-cost, portable, easy-to-use bacteria biosensor that can detect the presence of live bacteria in real time.

Patent No.Title
US 7,651,843Acoustic wave biosensor for the detection and identification of characteristic signaling molecules in a biological medium
US 8,420,382Acoustic wave biosensor for the detection and identification of characteristic signaling molecules in a biological medium
CA 2520812Method and system for archiving biomedical data generated by a data collection device

This portfolio covers an invention that detects, isolates and characterizes the QS signals made by both Gram Positive and Gram Negative bacteria. It creates a low-cost, small and portable testing unit for at-home, in-clinic, in-facility or in-field use. It can detect bacteria in either vapor or liquid, as a breathalyzer-type bacteria monitor, or a unit that can be placed in a location to sample the surrounding air for bacterial-signaling molecules.

In addition to the two U.S. Patents and the Canadian Patent, this portfolio includes working prototypes, so the company that acquires this property will be able to go to market very quickly with a bacteria biosensor that is cheaper than current products, produces results faster, and can be used in many more locations and applications!

ID/Medical Data/Alerts System (Solomon Systems): Five U.S. Patents

What happens when a person needs medical attention, but that person is unconscious? Or seriously injured or disabled? Or cannot speak? Or is disoriented and not totally lucid? It is difficult to provide medical care without at least some basic health information about that person. This challenge – an increasingly common occurrence – is what the invention covered by this portfolio addresses.

This portfolio covers a health-record provisioning system with multiple advantages:

The portfolio includes U.S. Patent Nos. 8,181,862, 8,485,439, 8,833,649, 9,165,335 and 9,390,231 titled "System for Providing Identification and Information, and for Scheduling Alerts." Included in the portfolio are two Chinese Patent Applications and a PCT Application. Technology covered by this portfolio has the capabilities to save lives, and it would give a critical competitive advantage to a healthcare provider, electronic device OEM or smartcard provider.

Ultrasound-Based Diagnostic Medical Imaging (Ramot University): Five U.S. Patents

This five-patent portfolio includes methods and systems to improve ultrasound-based diagnostic medical imaging. While ultrasounds have been used for over 50 years to image the human body and diagnose diseases. This portfolio discloses technology that advances the technology in several ways:

Patent No.Description
6,858,007Method and system for automatic classification and quantitative evaluation of adnexal masses based on a cross-sectional or projectional images of the adnex SOLD!
7,676,091Method and apparatus for analyzing ultrasound images

Logical acquirers of this technology include ultrasound imaging equipment OEMs, medical device and software providers, and medical research institutions.

Patent Brokerage Prospectus: Contact [email protected] to receive an analysis of each portfolio that includes:

We offer patents in these technologies: